Ellerhorst JA - Search Results

1

Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.

Ellerhorst JA, Sella A, Amato RJ, Tu SM, Millikan RE, Finn LD, Banks M, Logothetis CJ. Ellerhorst JA, et al. Cancer. 1997 Dec 1;80(11):2128-32. Cancer. 1997. PMID: 9392335 Clinical Trial.

2

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.

Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ. Logothetis CJ, et al. Among authors: ellerhorst ja. J Clin Oncol. 1995 Sep;13(9):2272-7. doi: 10.1200/JCO.1995.13.9.2272. J Clin Oncol. 1995. PMID: 7666085 Clinical Trial.

3

Phase II trial of low dose gamma-interferon in metastatic renal cell carcinoma.

Ellerhorst JA, Kilbourn RG, Amato RJ, Zukiwski AA, Jones E, Logothetis CJ. Ellerhorst JA, et al. J Urol. 1994 Sep;152(3):841-5. doi: 10.1016/s0022-5347(17)32587-9. J Urol. 1994. PMID: 8051732 Clinical Trial.

4

Intraabdominal desmoplastic small cell tumor. Report and discussion of five cases.

Amato RJ, Ellerhorst JA, Ayala AG. Amato RJ, et al. Among authors: ellerhorst ja. Cancer. 1996 Aug 15;78(4):845-51. doi: 10.1002/(SICI)1097-0142(19960815)78:4<845::AID-CNCR22>3.0.CO;2-U. Cancer. 1996. PMID: 8756380

5

Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer.

Ellerhorst JA, Tu SM, Amato RJ, Finn L, Millikan RE, Pagliaro LC, Jackson A, Logothetis CJ. Ellerhorst JA, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2371-6. Clin Cancer Res. 1997. PMID: 9815636 Clinical Trial.

6

A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies.

Tu SM, Robinson ED, Amato RJ, Ellerhorst JA, Kilbourn RG, Logothetis CJ. Tu SM, et al. Among authors: ellerhorst ja. Urol Oncol. 1995 Jul-Aug;1(4):156-60. doi: 10.1016/1078-1439(95)00057-7. Urol Oncol. 1995. PMID: 21224110

7

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

8

Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancer.

Sella A, Kilbourn RG, Gray I, Finn L, Zukiwski AA, Ellerhorst J, Amato RJ, Logothetis CJ. Sella A, et al. Cancer Biother. 1994 Summer;9(2):103-11. doi: 10.1089/cbr.1994.9.103. Cancer Biother. 1994. PMID: 7812360 Clinical Trial.

9

5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.

Logothetis CJ, Hossan E, Recondo G, Sella A, Ellerhorst J, Kilbourn R, Zukiwski A, Amato R. Logothetis CJ, et al. Anticancer Res. 1994 May-Jun;14(3B):1265-9. Anticancer Res. 1994. PMID: 8067694 Clinical Trial.

10

A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma.

Amato R, Meyers C, Ellerhorst J, Finn L, Kilbourn R, Sella A, Logothetis C. Amato R, et al. Ann Oncol. 1995 Nov;6(9):911-4. doi: 10.1093/oxfordjournals.annonc.a059358. Ann Oncol. 1995. PMID: 8624294 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters